|
Volumn 60, Issue 18, 2000, Pages 5151-5157
|
Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP
a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLIC GMP;
GUANYLIN;
UROGUANYLIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CANCER INHIBITION;
CANCER PREVENTION;
COLON ADENOCARCINOMA;
COLORECTAL CANCER;
CONTROLLED STUDY;
DRUG EFFICACY;
DUODENUM;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
ILEUM;
INTESTINE POLYP;
JEJUNUM;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
ADENOCARCINOMA;
ADENOMATOUS POLYPOSIS COLI;
AGED;
AGED, 80 AND OVER;
AMINO ACID SEQUENCE;
ANIMAL;
APOPTOSIS;
CACO-2 CELLS;
COLONIC NEOPLASMS;
CYCLIC GMP;
DOWN-REGULATION;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMAN;
MALE;
MICE;
MICE, INBRED C57BL;
MIDDLE AGE;
MOLECULAR SEQUENCE DATA;
PEPTIDES;
RECEPTORS, CELL SURFACE;
RNA, MESSENGER;
TUMOR CELLS, CULTURED;
|
EID: 0034665151
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (187)
|
References (39)
|